TrialBMC medicine2008

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden.

Andrew J Vickers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.